University of Nebraska
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Nebraska sits in the top decile of US sponsors by registered trial count (#90 of 15,742 sponsors by registered trial count).
University of Nebraska: 407 sponsored US clinical trials, 51 recruiting.
University of Nebraska sponsors 407 registered US clinical trials on ClinicalTrials.gov, 51 of them currently recruiting, and 261 completed. 31 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Peripheral Arterial Disease, with 7 trials.
Top-decile sponsor footprint
University of Nebraska ranks in the top decile of sponsors by registered trial count (#90 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
261 of 332 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
407 total, page 6 of 9
Echo Detection of Endoscopic Retrograde Cholangiopancreatography (ERCP) Air Embolus
NCT01535248
Use of Strattice Mesh in Paraesophageal Hernia Surgery
NCT01678157
Effect of Mobile Phone Telemedicine on Diabetes Care
NCT01698008
Serum 25-hydroxy Vitamin D [25(OH)D] Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants
NCT01469650
Diaphragmatic Breathing Retraining in Heart Failure Patients: Health-Behavior Related Outcomes
NCT01478932
The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
NCT01371877
Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
NCT01200082
Biomarkers for Prognosis of Glioblastoma (GBM)
NCT01493219
Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant
NCT01431209
First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
NCT01365884
Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma
NCT01336933
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
NCT01390194
Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
NCT01336920
Web-Based Weight Loss & Weight Maintenance Intervention for Older Rural Women, Also Known as Women Weigh-in for Wellness
NCT01307644
Stem Cells Predicting Orthopedic Outcomes
NCT01366911
Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Manifest Refraction and Autorefraction Results
NCT01342393
Physical Activity Telehealth Intervention After Percutaneous Coronary Procedures
NCT01673100
Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer
NCT01307956
Impact of a High-fat Meal on Assessment of Clopidogrel-induced Platelet Inhibition in Healthy Subjects
NCT01307657
IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic
NCT01254149
Awakening-Breathing Coordination, Delirium Monitoring/Management & Early Mobility (ABCDE) Protocol
NCT01413009
Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment
NCT01220674
Effect of Rosuvastatin Response in Healthy Subjects: Potential Mechanisms of Anti-inflammatory Effects
NCT00874757
Measurement of Plasma and Intracellular Concentrations of Raltegravir
NCT01214486
Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors
NCT01206465
Mechanisms That Produce the Leg Dysfunction of Claudication & Treatment Strategies
NCT01970332
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
NCT01342406
Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery
NCT01156129
Chronic HIV Infection and Aging in NeuroAIDS (CHAIN)
NCT01186042
Aqueous Humor Dynamics and Brimonidine
NCT01144494
Echocardiography Management for Patients Requiring Care for Non-Cardiac Surgery
NCT01050361
Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis
NCT01156155
The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry
NCT01409798
Maximizing Outcomes Needed After Percutaneous Coronary Intervention (PCI) Using Weight Management (MOMENTUM)
NCT01163968
Impact of Race/Ethnicity on Platelet Function
NCT01168622
Diode Laser Study for Periodontal Maintenance Patients
NCT01215201
Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT01060384
Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery
NCT01106898
Melatonin CR for the Treatment of Impaired Sleep Maintenance in 4-8 Year Old Children With Autism Spectrum Disorders
NCT01033565
Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer
NCT01093183
Developing Genetic Education for Smoking Cessation
NCT01186016
Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation
NCT01007357
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer
NCT01044745
Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma
NCT01035463
Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia
NCT01002586
Alcohol Exposure and Airway Hyperresponsiveness
NCT00990275
Herbal Lollipops on Oral Bacterial Levels and DMFT/Dmft Scores of Children With Asthma Using Inhalers
NCT01147835
Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema
NCT00876369
Continuous Hemoglobin Monitoring in Pediatric Transplant
NCT00958984
Vitamin D Status and Dose Response in Infants
NCT01042561
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 52 |
| Phase 3 | 10 |
| Phase 4 | 21 |
Therapeutic Areas
What is open in the University of Nebraska pipeline
51 recruiting of 407 indexed (13% open); 261 completed (64%).
Phase mix: 31 late (III/IV) vs 109 early (I/II) (early-phase heavy).
Top condition: Peripheral Arterial Disease (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Nebraska: open-pipeline peers nationwide
Peers matched on 407 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Nebraska sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 407 trials (± recruiting share)
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
- Takeda · 408 trials · 12% recruiting
- University of Kansas Medical Center · 408 trials · 23% recruiting
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this University of Nebraska page
407 registered trials is a research-attention snapshot, not an endorsement of University of Nebraska or any single study.
- 51 of University of Nebraska's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Peripheral Arterial Disease is the condition University of Nebraska studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Peripheral Arterial Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Nebraska pipeline card: 407 registered trials from official public datasets.Report a data error.